ArticleHead & neck2020
Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
Article in Head & neck, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- The effect of changing COVID-19 restrictions on the transmission rate in a veterinary clinic.Infectious Disease Modelling · 2023Article
- Impact of COVID-19 on older adults with cancer and their caregivers' cancer treatment experiences study: The ICE-OLD study.PloS one · 2023Article
- Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?Medical oncology (Northwood, London, England) · 2021Review
- Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).Medical oncology (Northwood, London, England) · 2020Article
- Disease progression of cancer patients during COVID-19 pandemic: a comprehensive analytical strategy by time-dependent modelling.BMC medical research methodology · 2020Article
- Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?Oral oncology · 2020Article
- Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.Head & neck · 2020Article
- Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.Head & neck · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe coronavirus infection is rapidly spreading, putting a strain on health care services across the globe. Patients with oral cancer are susceptible often immunosuppressed due to the disease and/or the treatment received.
methodsWe performed a simulation of the currently available data using a multistate and hazards model to provide an objective model for counseling and decision making for health care workers.
resultsStage IV patients with oral cancer who did not receive treatment had progression of disease and an increased mortality rate compared to patients who receive treatment but did not contract COVID-19. The patients who received treatment and got affected with COVID-19 had a far worse impact and higher mortality rate than all other groups.
conclusionIsolation and deferring treatment for stage IV patients with oral cancer, so as to avoid hospital visits and contraction of COVID-19, is an advisable strategy based on this model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.